Haitham Tuffaha

I am the lead of the Effective and Efficient Healthcare program at the Centre for the Business and Economics of Health at The University of Queensland. I also lead Health Technology Assessment for the Centre, which involves evaluating submissions made to the Australian Government to reimburse new medicines and medical devices through the Pharmaceutical benefits Scheme (PBS) and the Medicare Benefits Schedule (MBS). My research is focused on the economic evaluation of health interventions to inform decision making and promote value-based health care. I have pioneered the application of Value of Information (Research) analysis to enhance the efficiency of clinical trials and maximise the return on investment from medical research.

I have extensive experience working with key stakeholders including consumers, clinicians, decision makers and researchers. I am chief investigator on over $45 million Category 1 grants from the NHMRC, MRFF and ARC. In addition, I lead several projects for the Department of Health and other peak organisations.

I chair the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)-Oncology GroupI, and I am the past chair of the Clinical Oncology Society of Australia's (COSA)-Epidemiology Group and the Australian Clinical Trials Alliance (ACTA)-Research Prioritisation Group. I am an Associate Editor for Value in Health, and an Editorial Board Member for Medical Decision Making and PharmacoEconomics-open journals.